News | January 31, 2008

Heart Disease Ranked Most Expensive of Top 10 Health Conditions

February 4, 2008 - Heart conditions cost $76 billion to treat in 2005, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

The nation’s 10 most expensive medical conditions costs totaled an estimated $500 billion to treat in 2005, said the survey. This includes money paid for visits to doctor's offices, clinics and emergency departments, hospital stays, home health care and prescription medicines.

Estimated spending for the 10 most expensive conditions:
1. Heart conditions $76 billion
2. Trauma disorders $72 billion
3. Cancer $70 billion
4. Mental disorders, including depression $56.0 billion
5. Asthma and chronic obstructive pulmonary disease $54 billion
6. High blood pressure $42 billion
7. Type 2 diabetes $34 billion
8. Osteoarthritis and other joint diseases $34 billion
9. Back problems $32 billion
10.Normal childbirth $32 billion

AHRQ, which is part of the U.S. Department of Health and Human Services, works to enhance the quality, safety, efficiency and effectiveness of health care in the United States. The data in this AHRQ News and Numbers summary are taken from the Medical Expenditure Panel Survey, a detailed source of information on the health services used by Americans, the frequency with which they are used, the cost of those services and how they are paid.

For more information: www.ahrq.org

Related Content

Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
New Study Focuses on Protein Responsible For Increased Heart Disease Risk
News | Cardiac Diagnostics| August 03, 2017
August 3, 2017 — A study to reduce the strongest inherited...
Overlay Init